{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:29:04Z","timestamp":1778977744031,"version":"3.51.4"},"reference-count":59,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,3]]},"abstract":"<jats:p>Growing interest in mass vaccination with oral cholera vaccine in endemic and epidemic settings will require policymakers to evaluate how to allocate these vaccines in the most efficient manner. Because cholera, when treated properly, has a low case fatality rate, it may not be economically feasible to vaccinate an entire population. Using a new publicly available calculator for estimating the cost-effectiveness of mass vaccination, we show how targeting high-risk subpopulations for vaccination could be cost-effective in Bangladesh. The approach described here is general enough to adapt to different settings or to other vaccine-preventable diseases.<\/jats:p>","DOI":"10.4269\/ajtmh.14-0159","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:14:20Z","timestamp":1412727260000},"page":"1181-1189","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of Targeted Mass Cholera Vaccination Strategies in Bangladesh: A Demonstration of a New Cost-Effectiveness Calculator"],"prefix":"10.4269","volume":"91","author":[{"given":"Christopher","family":"Troeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis L.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Cholera: The Biography","author":"Hamlin","year":"2009"},{"key":"R2","series-title":"Bull World Health Organ","first-page":"209","article-title":"The global burden of cholera","volume":"90","author":"Ali","year":"2012"},{"key":"R3","series-title":"Am J Trop Med Hyg","first-page":"671","article-title":"Cholera vaccination in urban Haiti","volume":"89","author":"Rouzier","year":"2013"},{"key":"R4","series-title":"Vaccine","first-page":"6058","article-title":"Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh","volume":"31","author":"Khan","year":"2013"},{"key":"R5","series-title":"PLoS Negl Trop Dis","first-page":"e2465","article-title":"First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012","volume":"7","author":"Luquero","year":"2013"},{"key":"R6","series-title":"Am J Trop Med Hyg","first-page":"617","article-title":"Use of oral cholera vaccine in Haiti: a rural demonstration project","volume":"89","author":"Ivers","year":"2013"},{"key":"R7","series-title":"PLoS Med","first-page":"e1001512","article-title":"Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea","volume":"10","author":"Ciglenecki","year":"2013"},{"key":"R8","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"700","article-title":"Infection: mass vaccination is feasible in response to cholera epidemics","volume":"10","author":"Saha","year":"2013"},{"key":"R9","series-title":"Emerg Infect Dis","first-page":"2105","article-title":"Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010\u20132011","volume":"17","author":"Date","year":"2011"},{"key":"R10","series-title":"The World Health Organization Global Taskforce on Cholera Control","article-title":"WHO Policy and Recommendations","author":"Prevention and Control of Cholera Outbreaks","year":"2013"},{"key":"R11","series-title":"Health Econ","first-page":"235","article-title":"Development of WHO guidelines on generalized cost-effectiveness analysis","volume":"9","author":"Murray","year":"2000"},{"key":"R12","series-title":"JAMA","first-page":"1253","article-title":"Recommendations of the panel on cost-effectiveness in health and medicine","volume":"276","author":"Weinstein","year":"1996"},{"key":"R13","series-title":"JAMA","first-page":"1172","article-title":"The role of cost-effectiveness analysis in health and medicine","volume":"276","author":"Russell","year":"1996"},{"key":"R14","series-title":"Health Policy Plan","first-page":"326","article-title":"Calculating and presenting disability-adjusted life years (DALYs) in cost-effectiveness analysis","volume":"16","author":"Fox-Rushby","year":"2001"},{"key":"R15","series-title":"Disease Control Priorities in Developing Countries","first-page":"271","article-title":"Cost-effectiveness analysis for priority setting","author":"Musgrove","year":"2006"},{"key":"R16","series-title":"Vaccine","first-page":"2356","article-title":"WHO Guide for standardization of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010"},{"key":"R17","series-title":"Vaccine Introduction Guidelines: Adding a Vaccine to a National Immunization Programme: Decision and Implementation","author":"WHO","year":"2005"},{"key":"R18","series-title":"BMC Med","first-page":"55","article-title":"Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal","volume":"9","author":"Hutubessy","year":"2011"},{"key":"R19","series-title":"Vaccine","first-page":"2762","article-title":"Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia","volume":"23","author":"DeRoeck","year":"2005"},{"key":"R20","series-title":"Pharmacoeconomics","first-page":"525","article-title":"Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines","volume":"32","author":"Newall","year":"2014"},{"key":"R21","series-title":"Country Investment Case Study on Cholera Vaccination: Bangladesh","author":"Lopez","year":"2012"},{"key":"R22","series-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis","author":"Tan-Torres Edejer","year":"2003"},{"key":"R23","series-title":"BMC Infect Dis","first-page":"518","article-title":"Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective","volume":"13","author":"Sarker","year":"2013"},{"key":"R24","series-title":"Value Health","first-page":"899","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"Jeuland","year":"2009"},{"key":"R25","series-title":"Guidance Note on the Use of Oral Cholera Vaccines for UNICEF","author":"UNICEF","year":"2012"},{"key":"R26","series-title":"Population Distribution by Age Group, Sex, and Locality 2008","author":"Bangladesh Bureau of Statistics","year":"2013"},{"key":"R27","series-title":"J Health Popul Nutr","first-page":"299","article-title":"When should cholera vaccine be used in cholera-endemic areas?","volume":"21","author":"Sack","year":"2003"},{"key":"R28","series-title":"Lancet Infect Dis","first-page":"1050","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomized, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013"},{"key":"R29","series-title":"Cochrane Database Syst Rev","first-page":"CD008603","article-title":"Oral vaccines for preventing cholera","volume":"16","author":"Sinclair","year":"2011"},{"key":"R30","series-title":"PLoS Negl Trop Dis","first-page":"e2629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014"},{"key":"R31","series-title":"Wkly Epidemiol Rec","first-page":"214","article-title":"Oral cholera vaccine campaign among internally displaced persons in South Sudan","volume":"89","year":"2014"},{"issue":"(Suppl 1)","key":"R32","series-title":"J Infect Dis","first-page":"S15","article-title":"Strategy, demand, management, and costs of an international cholera vaccine stockpile","volume":"208","author":"Maskery","year":"2013"},{"key":"R33","series-title":"Vaccine","first-page":"2444","article-title":"Can oral cholera vaccination play a role in controlling a cholera outbreak?","volume":"22","author":"Calain","year":"2004"},{"key":"R34","series-title":"PLoS Negl Trop Dis","first-page":"e1844","article-title":"Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar","volume":"6","author":"Schaetti","year":"2012"},{"key":"R35","series-title":"Lancet","first-page":"223","article-title":"Cholera","volume":"363","author":"Sack","year":"2004"},{"key":"R36","series-title":"Lancet","first-page":"2129","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2012"},{"key":"R37","series-title":"The World Bank","author":"Bangladesh","year":"2014"},{"key":"R38","series-title":"An Investment Case for the Accelerated Introduction of Oral Cholera Vaccines","author":"Levin","year":"2012"},{"key":"R39","series-title":"Lancet","first-page":"44","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005"},{"key":"R40","series-title":"PLoS Med","first-page":"e336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007"},{"key":"R41","series-title":"Lancet","first-page":"270","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990"},{"key":"R42","series-title":"PLoS Negl Trop Dis","first-page":"e1901","article-title":"Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau","volume":"6","author":"Azman","year":"2012"},{"key":"R43","series-title":"PLoS Negl Trop Dis","first-page":"e999","article-title":"Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh","volume":"5","author":"Chowdhury","year":"2011"},{"key":"R44","series-title":"Int J Health Geogr","first-page":"45","article-title":"Application of Poisson kriging to the mapping of cholera and dysentery incidence in an endemic area of Bangladesh","volume":"5","author":"Ali","year":"2006"},{"key":"R45","series-title":"PLoS Negl Trop Dis","first-page":"e173","article-title":"The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa","volume":"2","author":"Deen","year":"2008"},{"key":"R46","series-title":"PLoS Negl Trop Dis","first-page":"e2545","article-title":"The burden of cholera in Uganda","volume":"7","author":"Bwire","year":"2013"},{"key":"R47","series-title":"Am J Epidemiol","first-page":"245","article-title":"Reaching hard-to-reach individuals: nonselective versus targeted outbreak response vaccination for measles","volume":"179","author":"Minetti","year":"2013"},{"key":"R48","series-title":"Curr Top Microbiol Immunol","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/82_2014_369","article-title":"Cholera outbreaks in Africa","volume":"379","author":"Mengel","year":"2014"},{"key":"R49","series-title":"J Diarrhoeal Dis Res","first-page":"79","article-title":"Cholera epidemics in Bangladesh: 1985\u20131991","volume":"10","author":"Siddique","year":"1992"},{"key":"R50","series-title":"N Engl J Med","first-page":"599","article-title":"Cholera surveillance during the Haiti epidemic\u2013the first 2 years","volume":"368","author":"Barzilay","year":"2013"},{"key":"R51","series-title":"Epidemiol Infect","first-page":"2083","article-title":"Recurrent epidemic cholera with high mortality in Cameroon: persistent challenges 40 years into the seventh pandemic","volume":"141","author":"Cartwright","year":"2013"},{"issue":"(Suppl 1)","key":"R52","series-title":"J Infect Dis","first-page":"S69","article-title":"A national cholera epidemic with high case fatality rates\u2013Kenya 2009","volume":"208","author":"Loharikar","year":"2013"},{"key":"R53","series-title":"N Engl J Med","first-page":"1060","article-title":"A lion in our village\u2013the unconscionable tragedy of cholera in Africa","volume":"360","author":"Mintz","year":"2009"},{"key":"R54","series-title":"Am J Trop Med Hyg","first-page":"7","article-title":"Cholera in Haiti: the equity agenda and the future of tropical medicine","volume":"86","author":"Farmer","year":"2012"},{"key":"R55","series-title":"Lancet Infect Dis","first-page":"837","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012"},{"key":"R56","series-title":"Vaccine","first-page":"96","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012"},{"key":"R57","series-title":"Cochrane Database Syst Rev","first-page":"CD009029","article-title":"Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) Diarrhea","volume":"7","author":"Ahmed","year":"2013"},{"key":"R58","series-title":"Bull World Health Organ","first-page":"714","article-title":"Stockpiling oral cholera vaccine","volume":"90","author":"Martin","year":"2012"},{"key":"R59","series-title":"Cholera Vaccine Investment Strategy","author":"GAVI","year":"2013"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/91\/6\/article-p1181.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/91\/6\/article-p1181.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/91\/6\/article-p1181.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T21:05:57Z","timestamp":1723064757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/91\/6\/article-p1181.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,3]]},"references-count":59,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.14-0159","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,3]]}}}